Advances in Vascular Medicine / 2014 / Article / Tab 1

Research Article

The Impact of Warfarin on Patients with End Stage Renal Disease

Table 1

Comparison of the demographics and comorbidities of patients with end stage renal disease with and without warfarin from the 2005–2010 National Inpatient Sample.

ESRD with warfarinESRD without warfarin

Number32,737895,077

Demographics
Age in years ± SD64.1 ± 15.761.1 ± 16.1<0.001
Female (%)49.0%48.0%NS
Caucasian (%)54.6%42.8%<0.001

Comorbid conditions
Amputation4.6%3.6%<0.001
CHF23.0%21.0%<0.001
COPD21.0%18.0%<0.001
CVA7.9%3.8%<0.001
DM28.0%25.0%<0.001
HTN76.0%75.0%<0.001
MI8.6%6.0%<0.001
PVD16.0%15.0%<0.001
Valve13.0%5.0%<0.001